Dr. Golumbek'sspecific interests include disorders of the brain, spinal cord, nerves, and muscles, aswell as general pediatric neurology and neuromuscular diseases.

Medical Training

B.A.: University of Maryland, Baltimore County, Maryland, 1985

M.S.: Applied Molecular Biology, University of Maryland, Baltimore County, Maryland, 1985

M.D., Ph.D.: Johns Hopkins School of Medicine, Baltimore, Maryland, 1995

Residency: Pediatric Neurology, University of Washington, Seattle, Washington, 1999

Fellowship: Electrophysiology, Veterans Administration Hospital, Puget Sound, Washington, 2002

Research Fellowship: Washington University School of Medicine, St. Louis, Missouri, 2004

Selected Publications

Cross AH, Golumbek PT. Neurologic manifestations of celiac disease: Proven, or just a gut feeling? Neurology 2003 May 27;60(10):1566-8

Hatamochi A, Golumbek PT, Van schaftingen E, deCrombrugghe B. A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem 1988; Apr25;263(12):5940-7

Maity SN, Golumbek PT, Karsenty G, de Crombruggghe B. Selective activation of transcription by a novel CCAAT binding factor. Science 1988;Jul 29;241(4865):582-5

Karsenty G, Golumbek P, de Crombrugghe B. Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse alpha 2(1) collagen promoter. J Biol Chem 1988; Sep 25:263(27):13909-15

Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons WJ, Karasuyama H,m Vogelstein B, Frost P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990; Feb 9;60(3):397-403

Levitksy HI, Golumbek PT, Pardoll DM. The fate of DC4-8- T cell receptor-alpha beta+ thymocytes. J Immunol 1991; Feb15;146(4):1113-7